Current and emerging treatments based on novel mechanisms for immune thrombocytopenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging treatments based on novel mechanisms for immune thrombocytopenia

Published:2020-08-07 Issue:10 Volume:63 Page:1597-1599
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

Zeng Qiaozhu,Zhang Xiaohui

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s11427-020-1757-2.pdf

Reference15 articles.

1. Al-Samkari, H., and Kuter, D.J. (2018). An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia. Br J Clin Pharmacol 84, 2673–2677.

2. Boccia, R., Boxer, M.A., Ghanima, W., Hill, Q.A., Sholzberg, M., Tarantino, M.D., Kreychman, Y., Numerof, R.P., Olender, B., Todd, L., et al. (2019). Enhanced responses to fostamatinib as second-line therapy and in persistent immune thrombocytopenia (ITP) patients. Blood 134, 1069.

3. Bussel, J.B., Saleh, M.N., Vasey, S.Y., Mayer, B., Arning, M., and Stone, N. L. (2013). Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP). Br J Haematol 160, 538–546.

4. Bussel, J., Arnold, D.M., Grossbard, E., Mayer, J., Trelihski, J., Homenda, W., Hellmann, A., Windyga, J., Sivcheva, L., Khalafallah, A.A., et al. (2018). Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials. Am J Hematol 93, 921–930.

5. Dai, L., Zhang, R., Wang, Z., He, Y., Bai, X., Zhu, M., Yu, Z., and Ruan, C. G. (2016). Efficacy of immunomodulatory therapy with all-trans retinoid acid in adult patients with chronic immune thrombocytopenia. Thromb Res 140, 73–80.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine-associated thrombocytopenia;Thrombosis Research;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3